On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer, HIV and other conditions. The post Healthcare Leaders Support FTC’s…
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall. The post Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s? appeared first on MedCity News.
[Sponsored] In this whitepaper, ProviderTrust outlines the overwhelmingly positive survey results and compares them to our experiences getting up close and personal with the provider data in question. The post Is Payers’ Provider Data “Clean, Complete, and Centralized” or is There a Crisis of Overconfidence? appeared first on MedCity News.
Vida Health is partnering with ŌURA to use data from the Oura Ring to provide more continuous, personalized cardiometabolic care and improve patient outcomes. The post Vida Health Teams Up with ŌURA to Provide More Personalized Metabolic Care appeared first on MedCity News.
For the triage nurse, it comes down to understanding nuance and unique patient needs, whether that’s identifying an acute condition or just lending a listening ear. The post Listen Closer: What Triage Nurses Hear That Others Miss appeared first on MedCity News.
The current system is failing vulnerable patients – those it was designed to help. While well-intentioned, the savings these programs promise rarely trickle down to patients. The post The Dysfunctional Drug Discount System’s Serious Implications on Patient Health appeared first on MedCity News.
Numerous advocacy organizations are sounding the alarm over a recent HHS notice that restricts access to federal benefits for undocumented immigrants, as well as for those lawfully present. The post Why HHS’ Notice On Federal Public Benefits Harms Both Lawfully Present and Undocumented Immigrants appeared first on MedCity News.
Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill. For six months in 2022, Manski received monthly infusions of nivolumab to fight advanced melanoma. The drug ruined his thyroid gland, he…
On the last day of patient care at the Planned Parenthood clinic in Marquette, Michigan, a port town on the shore of Lake Superior, dozens of people crowded into the parking lot and alley, holding pink homemade signs that read “Thank You!” and “Forever Grateful.” “Oh my god,” physician assistant Anna Rink gasped, as she…
This isn’t a political issue, it’s a public health challenge with real consequences for kids’ futures. As reality sets in, we must face the possibility of a post-fluoridation era and find new ways to give kids in at-risk communities a fair shot at a healthy smile. The post Beyond Politics: Payer Solutions for Fluoride-free Communities…